Search results for "mRNA"
mRNA Therapeutics and Vaccines – Key Process Considerations
Click here >> Learn more on key considerations and strategies for process development and scaling up in our new web hub for mRNA therapeutics and vaccines.
mRNA Processing Workflow for Vaccines and Therapeutics
CLICK HERE TO VIEW >> Learn more on key considerations when setting up a messenger RNA (mRNA) process with this infographic.
mRNA Vaccines: Current Trends and Perspectives
There are still challenges to overcome to fully realize the potential of this technology, but the COVID-19 pandemic publicly demonstrated the promise of mRNA therapies. The future looks bright for thi…
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >> The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Process Development challenges for mRNA vaccines and beyond
Key insights from industry experts on the future of therapeutic mRNA manufacturing. READ MORE >>
mRNA vaccines: current trends and perspectives
The promise and challenges of mRNA vaccine development. READ MORE >>
Increasing mRNA capabilities and capacity for growing market needs
The rapid development of innovative vaccines allowed for the pharmaceutical industry to deliver its first tools in the fight against the COVID-19 pandemic. READ FULL ARTICLE >>
Analysis of mRNA Therapeutics and Vaccines
Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates. Read more here >>>
Cytiva to provide Arranta Bio 'idea to injection' solutions for integrated manufacturing of mRNA products
Cytiva will provide its FlexFactory single-use manufacturing platform to Arranta Bio ("Arranta"), a leading contract development and manufacturing organization (CDMO) for use in manufacturing mRNAv…
Genetic Vaccine Platforms Demonstrate Their Potential
Genetic vaccines include messenger RNA (mRNA)/DNA. Alternatively, vaccines can be classified into live and non-live vaccines, which is important when considering safety profiles. Traditional v…